Sacubitril/Valsartan in Advanced Heart Failure
Authors:
- 27 June 2022
- journal article
- editorial
- Published by Elsevier in JACC: Heart Failure
- Vol. 10 (7) , 457-458
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Identifying Treatments for Stage C2 Heart FailureJAMA Cardiology, 2022
- Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection FractionJAMA Cardiology, 2021
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart FailureNew England Journal of Medicine, 2019
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart FailureJACC, 2017
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart FailureNew England Journal of Medicine, 2014